Pelvic congestion syndrome and its treatment

1. Liddle AD, Davies AH. Pelvic congestion syndrome: chronic pelvic pain caused by ovarian and internal iliac varices. Phlebology 2007; 22(3): 100–104.

2. Hnátek L. Farmakoterapie chronického žilního onemocnění. Interní Med 2014; 16(3): 93–97.

3. Burak F, Gunduz T, Simsek M et al. Chronic pelvic pain associated with pelvic congestion syndrome and the benefit of Daflon 500 mg. A review. Phlebolymphology 2009; 16(3): 290–294.

4. Karetová D, Seifert B, Vojtíšková J et al. Chronická žilní onemocnění. Doporučené diagnostické a terapeutické postupy pro všeobecné praktické lékaře 2011. Centrum doporučených postupů pro praktické lékaře. Společnost všeobecného lékařství ČLS JEP: Praha 2011: 14. ISBN 978–80–86998–52–57. Dostupné z WWW: <http://www.svl.cz/files/files/Doporucene-postupy-2008–2012/Chron-zilni-onemocneni.pdf>.

5. Pascarella L. Essentials of Daflon 500 mg: from early valve protection to long-term benefits in the management of chronic venous disease. Current Pharmaceutical Design 2007;13(4):431–444.

6. Perrin M, Nicolaides A. The updates international guidelines on the management of chronic venous disorders of the lower limbs and the place of venoactive drugs. Int Angiol 2013; 32(Suppl1): 106–107.

7. Taskin O, Uryan II, Buhur A et al. The effects of Daflon on pelvic pain in women with Taylor syndrome. J Am Assoc Gynecol Laparosc 1996; 3(4 Suppl): S49

8. Simsek M, Burak F,Taskin O. Effects of micronized purified flavonoid fraction (Daflon) on pelvic pain in women with laparoscopically diagnosed pelvic congestion syndrome: a randomized crossover trial. Clin Exp Obstet Gynecol 2007; 34(2): 96–98.

9. Soylemez H, Kilic S, Atar M et al. Effects of micronised purified flavonoid fraction on pain, semen analysis and scrotal color Doppler parameters in patients with painful varicocele; results of a randomized placebo-controlled stud. Int Urol Nephrol 2012; 44(2): 401–408.